Not available
Quote | Boston Scientific Corporation (NYSE:BSX)
Last: | $76.55 |
---|---|
Change Percent: | 0.03% |
Open: | $76.39 |
Close: | $76.55 |
High: | $76.73 |
Low: | $75.91 |
Volume: | 3,307,518 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Boston Scientific Corporation (NYSE:BSX)
2024-07-02 09:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for BSX on July 2, 2024 08:01AM ET. The previous analyst recommendation was Outperform. BSX was trading at $76.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-07-01 12:35:40 ET More on Zimmer Biomet Zimmer Biomet Holdings: Moving Along Zimmer Biomet Holdings, Inc. (ZBH) Q1 2024 Earnings Call Transcript Zimmer Biomet down for third session in a row despite THINK Surgical agreement Argus upgrades Zimmer to buy, ...
Message Board Posts | Boston Scientific Corporation (NYSE:BSX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $BSX News Article - Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High | whytestocks | investorshangout | 04/05/2023 4:30:47 PM |
whytestocks: $BSX News Article - Boston Scientific ($BSX) Trading Report | whytestocks | investorshangout | 04/04/2023 4:50:48 PM |
whytestocks: $BSX News Article - Boston Scientific: One of Glassdoor's Best Places to Work in 2022 | whytestocks | investorshangout | 02/03/2022 8:55:48 PM |
whytestocks: $BSX News Article - Boston Scientific Corp (BSX) Q2 2021 Earnings Call Transcript | whytestocks | investorshangout | 07/27/2021 8:40:48 PM |
whytestocks: $BSX News Article - Boston Scientific Receives FDA Approval For The Vercise Genus(TM) D | whytestocks | investorshangout | 01/22/2021 1:35:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
2024-07-02 09:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for BSX on July 2, 2024 08:01AM ET. The previous analyst recommendation was Outperform. BSX was trading at $76.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Boston Scientific Announces Conference Call Discussing Second Quarter 2024 Results PR Newswire MARLBOROUGH, Mass. , July 1, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business h...